Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Subjects: ESTATINAS, HIPERCOLESTEROLEMIA
ABNT
HERNANDEZ, Carolina Dagli et al. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 10 nov. 2024. , 2018APA
Hernandez, C. D., Borges, J. B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdfNLM
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 nov. 10 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdfVancouver
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 nov. 10 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf